Abbott (ABT) slips as results, guidance barely meet consensus

Go back to Abbott (ABT) slips as results, guidance barely meet consensus

Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook

January 24, 2024 7:30 AM EST

Fourth-quarter reported sales increased 1.5 percent; organic sales growth for the underlying base business increased 11.0 percentFull-year 2023 reported sales decreased 8.1 percent due to anticipated decline in COVID-19 testing-related sales; organic sales growth for the underlying base business increased 11.6 percentFull-year 2023 GAAP diluted EPS of $3.26; adjusted diluted EPS of $4.44R&D pipeline continues to deliver steady cadence of new products

ABBOTT PARK, Ill., Jan. 24, 2024 /PRNewswire/ -- Abbott today announced financial results for the fourth... More